Thyroid Disease CARE Act of 2024
The source supplies the latest action, but no lifecycle stage.
Latest action (4 Dec 2024): Referred to the House Committee on Energy and Commerce.
What this bill does
The Thyroid Disease CARE Act of 2024 (H.R. 10297) would direct the Secretary of Health and Human Services to expand federal efforts on thyroid disease. It requires the Secretary, working with the National Academies of Sciences, Engineering, and Medicine, to conduct or support research into the causes, diagnosis, treatment, and survivorship of thyroid disease and thyroid cancer, and to study disparities in prevalence, detection, and outcomes across demographic groups. It also requires a separate analysis of research gaps and disproportionate impacts, drawing on data from Medicaid, Medicare, SEER, health plans, and national surveys, with privacy protections. The bill further directs a public awareness campaign for patients and providers, and interim, preliminary, and final reports to Congress by set deadlines. Funding of $30 million annually (2025–2029) is authorized for the research and analysis provisions, and $3 million annually for the awareness campaign.
The bill would primarily affect HHS, the National Institutes of Health, health researchers, health care providers, insurers, and Medicaid/CHIP programs, which may be asked to supply data. It aims to benefit patients with thyroid disease, particularly women and other populations identified as experiencing disparities in diagnosis or treatment.
H.R. 10297 was introduced on December 4, 2024, in the 118th Congress and referred to the House Committee on Energy and Commerce. It did not receive a vote before the end of that Congress, so it would need to be reintroduced in a future Congress to be considered further.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
4 Dec 2024
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 10297 do?
- The Thyroid Disease CARE Act of 2024 (H.R. 10297) would direct the Secretary of Health and Human Services to expand federal efforts on thyroid disease. It requires the Secretary, working with the National Academies of Sciences, Engineering, and Medicine, to conduct or support research into the causes, diagnosis, treatment, and survivorship of thyroid disease and thyroid cancer, and to study disparities in prevalence, detection, and outcomes across demographic groups. It also requires a separate analysis of research gaps and disproportionate impacts, drawing on data from Medicaid, Medicare, SEER, health plans, and national surveys, with privacy protections. The bill further directs a public awareness campaign for patients and providers, and interim, preliminary, and final reports to Congress by set deadlines. Funding of $30 million annually (2025–2029) is authorized for the research and analysis provisions, and $3 million annually for the awareness campaign. The bill would primarily affect HHS, the National Institutes of Health, health researchers, health care providers, insurers, and Medicaid/CHIP programs, which may be asked to supply data. It aims to benefit patients with thyroid disease, particularly women and other populations identified as experiencing disparities in diagnosis or treatment. H.R. 10297 was introduced on December 4, 2024, in the 118th Congress and referred to the House Committee on Energy and Commerce. It did not receive a vote before the end of that Congress, so it would need to be reintroduced in a future Congress to be considered further.
- Has H.R. 10297 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10297. Check the latest action and official source below.
- Who sponsored H.R. 10297?
- H.R. 10297 was sponsored by Rep. Stevens, Haley M. [D-MI-11] (D-MI), with 5 cosponsors.
- What's the latest action on H.R. 10297?
- Referred to the House Committee on Energy and Commerce. (4 Dec 2024).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Stevens, Haley M. [D-MI-11]
Data Science and Literacy Act of 2026
Supporting the designation of September 17, 2026, as "National Physician Suicide Awareness Day" to raise awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health conditions, and for other purposes.
Thyroid Disease CARE Act of 2025
Recognizing and supporting the continued efforts and contributions of the City of Ferndale to the LGBTQIA+ community of the State of Michigan.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.